<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2026.1612077</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The TPx protein of <italic>Taenia solium metacestode</italic> regulates Treg and Th17 cell differentiation via the TGF-&#x3b2;/Smad signaling pathway</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Sun</surname><given-names>Xiaoqing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2070236/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Mu</surname><given-names>Qianqian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3042280/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhou</surname><given-names>Biying</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1060719/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Parasitology, Zunyi Medical University</institution>, <city>Zunyi</city>,&#xa0;<country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>Binzhou Center for Disease Control and Prevention (Binzhou Key Laboratory of Emerging and Acute Infectious Diseases Research)</institution>, <city>Binzhou</city>,&#xa0;<country country="cn">China</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Biying Zhou, <email xlink:href="mailto:1458030871@qq.com">1458030871@qq.com</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-06">
<day>06</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>17</volume>
<elocation-id>1612077</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>11</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Sun, Mu and Zhou.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Sun, Mu and Zhou</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-06">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>The immunopathogenesis of cysticercosis remains elusive. This study investigates the effects of <italic>Taenia solium</italic> metacestode-derived thioredoxin peroxidase (TPx) protein on regulatory T (Treg) cells and T helper 17 (Th17) cell differentiation, as well as its correlation with signaling pathways in human Jurkat T lymphocytes exposed to TPx for varying durations, to provide a scientific basis for further studying the immune pathogenesis and clinical treatment of cysticercosis.</p>
</sec>
<sec>
<title>Methods</title>
<p>TPx protein from the excretory-secretory antigens of <italic>T. solium metacestode</italic> was used to stimulate Jurkat cells at various timepoints. Flow cytometry was employed to detect the expression of CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>-</sup> Treg cells and CD4<sup>+</sup>IL-17A<sup>+</sup> Th17 cells. Transcriptomic analysis was performed to identify the signaling pathways related to the differentiation of Jurkat cells under the influence of the TPx protein at different time points. The expression levels of TGF-&#x3b2;1, TGF-&#x3b2;R2, Smad4, Foxp3, RORC(&#x3b3;t), and phosphorylated Smad3 proteins were measured in TPx-treated cells and control cells at different time points.</p>
</sec>
<sec>
<title>Results</title>
<p>A Treg/Th17 cell imbalance was detected in Jurkat cells following exposure to TPx, characterized by a Treg-mediated predominant immunosuppressive response. Gene Set Enrichment Analysis identified significant enrichment of the TGF-&#x3b2; signaling pathway and Th17 cell differentiation pathway in TPx-treated cells. TPx significantly upregulated TGF-&#x3b2;1, TGF-&#x3b2;R2, and p-Smad3 expression in cells (<italic>P</italic> &lt; 0.05). Concurrently, the expression of Foxp3, a key transcriptional regulator of Treg cell differentiation, was markedly increased (<italic>P</italic> &lt; 0.05). In contrast, the expression of RORC(&#x3b3;t), a transcription factor critical for Th17 cell differentiation, showed significant reduction after 72 h of TPx induction (<italic>P</italic> &lt; 0.05).</p>
</sec>
<sec>
<title>Discussion</title>
<p>The TGF-&#x3b2;/Smad signaling pathway is a crucial molecular mechanism involved in the imbalance of Treg/Th17 cells induced by the TPx protein of <italic>T. solium metacestode</italic>.</p>
</sec>
</abstract>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<fig>
<caption><p>The TPx protein of Cysticercus cellulosae regulates the expression levels of Foxp3 and RORC (&#x3b3;t) by activating the TGF-&#x3b2;/Smad signaling pathway. Early (24 h) differentiation of Treg cells is slightly inhibited, while differentiation of Treg cells is promoted and differentiation of Th17 cells is inhibited in the mid to late stages (48 h, 72 h). This leads to an imbalance of host Treg/Th17 cells, resulting in an immune response predominantly characterized by Treg cells. This study primarily investigates the effects of the TPx protein on the differentiation of Treg and Th17 cells and its correlation with the TGF-&#x3b2;/Smad signaling pathway, providing important scientific evidence for further exploration of the immunopathogenesis of Cysticercosis.</p></caption>
<graphic xlink:href="fimmu-17-1612077-g000.tif" position="anchor">
<alt-text content-type="machine-generated">Illustration of TGF-beta signaling pathway at 0, 24, 48, and 72 hours showing Smad2/3 and Smad4 interaction. Graph depicts expression changes in Foxp3 and ROR-gamma-t, influencing Treg and Th17 cells. Results indicate shifts in immune tolerance and inflammation through TGF-beta, IL-10, and IL-17 expression levels.</alt-text>
</graphic>
</fig>
</p>
</abstract>
<kwd-group>
<kwd><italic>Taenia solium metacestode</italic></kwd>
<kwd>TGF-&#x3b2; signaling pathway</kwd>
<kwd>Th17 cells</kwd>
<kwd>thioredoxin peroxidase</kwd>
<kwd>Treg cells</kwd>
<kwd>Treg/Th17 cell balance</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">
<institution-wrap>
<institution>National Natural Science Foundation of China</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100001809</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This study was funded by National Natural Science Foundation of China (No. 82460402); National Natural Science Foundation of China (No. 81960378); Basic Research Plan of Department of Science and Technology of Guizhou Province (Qiankehe Foundation-ZK(2023) general 516); Science Foundation Project of Guizhou Provincial Health Commission (gzwkj2024-278).</funding-statement>
</funding-group>
<counts>
<fig-count count="9"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="33"/>
<page-count count="14"/>
<word-count count="5762"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Parasite Immunology</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>The pork tapeworm <italic>Taenia solium</italic> (<italic>T. solium</italic>) is a neglected zoonotic parasite that ranks first globally among parasitic causes of foodborne infections (<xref ref-type="bibr" rid="B1">1</xref>). Infections between humans and pigs perpetuate a vicious cycle (<xref ref-type="bibr" rid="B2">2</xref>). The severity of cysticercosis depends on the number of parasites and their location. According to the World Health Organization (WHO), neurocysticercosis (NCC) is considered a neglected tropical disease that affects approximately 50 million people globally, causing 50,000 deaths annually (<xref ref-type="bibr" rid="B3">3</xref>). Current treatments primarily involve medications and surgical interventions, both of which have limitations. The complex immune pathogenesis induced by <italic>T. solium metacestode</italic> is a significant barrier to the development of effective vaccines (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). Therefore, elucidation of the host immune regulation induced by <italic>T. solium metacestode</italic> is critically warranted.</p>
<p>CD4<sup>+</sup> T cells play a central role in anti-parasitic immunity, where the dynamic balance between Treg and Th17 cells is crucial for determining infection outcomes (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Our previous work demonstrated that excretory-secretory antigens (ESAs) from <italic>T. solium</italic> metacestodes can modulate host immune responses by activating the TGF-&#x3b2;/Smad signaling pathway (<xref ref-type="bibr" rid="B8">8</xref>). The TGF-&#x3b2;/Smad signaling pathway is a key regulator of T cell fate. Upon binding to its receptors (T&#x3b2;R-I/II), TGF-&#x3b2; activates Smad2/3 proteins, which then translocate to the nucleus (<xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B12">12</xref>). There, they modulate the expression of lineage-specific transcription factors, such as Foxp3 for Treg cells and ROR-&#x3b3;t for Th17 cells, thereby critically directing their differentiation (<xref ref-type="bibr" rid="B13">13</xref>; <xref ref-type="bibr" rid="B14">14</xref>). Notably, this pathway is often exploited by parasites to manipulate host T cell responses and promote immune evasion. Through proteomic analysis, we further identified the thioredoxin peroxidase (TPx) protein from these antigens and confirmed that TPx could induce Treg/Th17 imbalance in piglets, thereby facilitating immune evasion (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). The TPx protein of <italic>T. solium</italic> metacestode exhibits high sensitivity and specificity, making it a specific antigen for the diagnosis of cysticercosis and a potential candidate for vaccine development for immunoprophylaxis against this disease (<xref ref-type="bibr" rid="B17">17</xref>). However, the precise molecular mechanisms by which TPx regulates the differentiation of these cell subsets remain unclear.</p>
<p>Building on these findings, this study aimed to investigate the effect of <italic>T. solium</italic> metacestode TPx protein on the differentiation of human Treg and Th17 cells and to elucidate the underlying mechanisms. Using a Jurkat cell model, we analyzed the regulatory role of TPx on the differentiation of both cell types at different time points. Furthermore, we employed transcriptomics, flow cytometry, and Western blotting to verify the key involvement of the TGF-&#x3b2;/Smad signaling pathway in this process. Our work provides new experimental evidence for clarifying the mechanism of TPx-mediated immune evasion.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Preparation of <italic>T. solium metacestode</italic> TPx protein</title>
<p>Bioinformatics analysis was employed to predict the hydrophilicity and T cell antigenic epitopes of TPx protein. The TPx antigen-coding gene was synthesized using whole-gene synthesis technology. The gene was then cloned into the pcDNA3.4 vector to construct the recombinant plasmid pcDNA3.4-TPx. The recombinant plasmid was enzymatically digested and sequenced for verification. The plasmid was transfected into Expi 293 cells and the expressed TPx protein was purified using a Ni column (Endotoxin&lt;10 EU/mg). The purified protein was analyzed by SDS-PAGE and further confirmed by western blotting. The recombinant TPx protein was stored at &#x2212;80&#xb0;C.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Cultivation and activation of Jurkat cells</title>
<p>The Jurkat T cell model can simulate human T lymphocyte functions, and is widely used in <italic>in vitro</italic> studies of T cell signal transduction, cytokine production, and receptor expression. It also provides significant guidance and reference for the treatment and mechanistic research of various infectious diseases (<xref ref-type="bibr" rid="B18">18</xref>). Human leukemia T lymphocyte Jurkat cells, Clone E6-1 (hereinafter referred to as &#x201c;Jurkat cells&#x201d;), were purchased from the Shanghai Cell Bank of the Chinese Academy of Sciences. Cells from suspension culture were cultured in RPMI 1640 medium (Solarbio Sciences, China) containing 10% fetal bovine serum (Gibco, Australia) and antibiotics (100 &#x3bc;g/ml penicillin and 100 &#x3bc;g/ml streptomycin). Cells were treated with 0.5 ng/ml Phorbol-12-myristate-13-acetate (PMA) and 0.5 &#x3bc;M ionomycin for 12 hours to induce cell activation. Based on this, 500 ng/ml of TPx protein was used according to the schedule set for each experimental cell group.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Flow cytometry analysis</title>
<p>Activated Jurkat cells were washed with pre-cooled PBS (Meilunbio, China) and then treated with TPx protein (500 ng/mL) for 24 h, 48 h, and 72 h, while control cells were cultured with an equal volume of RPMI 1640 medium instead of TPx protein. All cells were cultured under standard conditions in 6-well plates at a density of 1&#xd7;10<sup>6</sup> cells/mL. Cells from each culture group were collected separately, counted, and set aside for later use. We collected a total of 1 &#xd7; 10<sup>6</sup> cells and washed them with pre-cooled PBS (Meilunbio, China). One group was incubated with appropriate amounts of allophycocyanin (APC)-labeled anti-human CD4 antibody (BD Pharmingen, USA), phycoerythrin (PE)-labeled anti-human CD25 antibody (BD Pharmingen, USA), and fluorescein isothiocyanate (FITC)-labeled anti-human CD127 antibody (Thermo Fisher, USA). The cells were mixed well and incubated on ice in the dark for 30 minutes. Another group was incubated with an appropriate amount of APC-labeled anti-human CD4 antibody (BD Pharmingen, USA), mixed well, and incubated on ice in the dark for 30 minutes. After fixation and membrane permeabilization (After fixation and membrane permeabilization, USA), an appropriate amount of peridinin-chlorophyll-protein complex-cyanine5.5 (PerCP-Cy5.5)-labeled anti-human IL-17A antibody (Thermo Fisher, USA) was added. The cells were mixed well and incubated on ice in the dark for 20 minutes. We then washed the cells and resuspended them in PBS for flow cytometry analysis (BD FACSAria III, USA).</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Transcriptome sequencing and bioinformatic analysis</title>
<p>Activated Jurkat cells were washed with pre-cooled PBS (Meilunbio, China) and then treated with TPx protein (500 ng/mL) for 0 h, 48 h, and 72 h, while control cells were cultured with an equal volume of RPMI 1640 medium instead of TPx protein, each experimental group consisted of three samples. Jurkat cells were cultured in a 6-well plate at a density of 1 &#xd7; 10<sup>6</sup> cells/well, at 37&#xb0;C with 5% CO<sub>2</sub>. After the completion of Jurkat cell culture, the cells were centrifuged at 1500 g for 10 min at 4&#xb0;C to remove the culture medium. Then, the cells were resuspended in PBS bufer (Solarbio Sciences, China) and centrifuged again at 1500 g for 10 min at 4&#xb0;C, followed by a quick wash. The cell pellets were resuspended in TRIzol (Takara, Japan) at a ratio of 1 ml per 1 &#xd7; 10<sup>6</sup> cells and vigorously pipetted until a clear and non-viscous liquid was formed. The lysate was then transferred to a new centrifuge tube. The extracted RNA samples were sent to Shanghai OE Biotech Co., Ltd. for quality inspection. After meeting the requirements, library construction was performed, and the library quality was evaluated. Finally, RNA-seq sequencing and sequence alignment were conducted with the assistance of Shanghai OE Biotech Co., Ltd.</p>
<p>The steps for constructing a transcriptome sequencing library include total RNA extraction, RNA quality assessment and fragmentation, reverse transcription to generate cDNA, end repair, A-tailing, adapter ligation, and PCR amplification, followed by RNA-seq sequencing and sequence alignment. Based on the transcriptome sequencing results, DESeq2 software was used with <italic>p</italic>-value &lt; 0.05 and fold change (FC) &gt; 2.0 or &lt; &#x2212;2.0 as criteria for significant differences, to identify differentially expressed protein-coding genes for Gene Ontology (GO) functional analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, and Gene Set Enrichment Analysis (GSEA) enrichment analysis.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Western blotting</title>
<p>Jurkat cells from each culture group were collected and resuspended in pre-cooled PBS for washing. Cells were then lysed in freshly prepared Radio-Immunoprecipitation Assay lysis buffer (Solarbio Sciences, China) on ice for 30 minutes, followed by centrifugation at 12,000 rpm for 20 minutes at 4 &#xb0;C. The supernatant was aspirated to obtain total cellular protein. Sample buffer was added, and the proteins were denatured by boiling for subsequent experiments (<xref ref-type="bibr" rid="B19">19</xref>).</p>
<p>After protein electrophoresis and membrane transfer, the membranes were blocked by soaking in 5% non-fat milk for 2 hours, then washed three times with Tris-Buffered Saline with Tween (TBST) buffer for 10 minutes each. The membranes were incubated with diluted primary antibodies against TGF-&#x3b2;1 (Thermo Fisher, USA), TGF-&#x3b2;R2 (Proteintech, China), Smad4 (Proteintech, China), Foxp3 (Thermo Fisher, USA), RORC(&#x3b3;t) (Proteintech, China), Smad3 (Thermo Fisher, USA), and p-Smad3 (Abcam, UK) on ice for over 12 hours. After incubation, the membranes were washed three times with TBST buffer for 10 minutes each. Goat anti-rabbit secondary antibody (Proteintech, China) was prepared in TBST buffer according to the antibody dilution ratio and incubated at room temperature for 1.5 hours. Finally, the membranes were washed three times with TBST buffer for 10 minutes each, and the proteins were detected using ECL reagent (Meilunbio, China).</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Statistical analysis</title>
<p>We used GraphPad Prism 8 for data visualization and SPSS 29.0 for statistical analysis. Data are expressed as mean &#xb1; standard deviation (x&#x304; &#xb1; SD, n = 3) using the independent sample t-test. <italic>P</italic> &lt; 0.05 was considered to indicate statistical significance.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>The effect of <italic>T. solium metacestode</italic> TPx protein on the differentiation of Treg and Th17 cells</title>
<p>TPx protein was applied to Jurkat cells for 24 h, 48 h, and 72 h. Control cells was included that did not receive TPx protein. The expression of CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>&#x2212;</sup> Treg cells in each sample was assessed using flow cytometry to examine the impact of TPx protein on Treg cell differentiation over time. As shown in <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>, compared with the control cells, TPx protein inhibited Treg cell differentiation at 24 h, with a significant difference (<italic>P</italic> &lt; 0.05), while its effect on Th17 cells was not significant. However, after 48 h and 72 h of TPx protein treatment, there was a significant induction of Treg cell differentiation and inhibition of Th17 cell differentiation (<italic>P</italic> &lt; 0.05).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Effect of TPx protein on the differentiation of Treg and Th17 cells (n = 3, x&#x304; &#xb1; S, %). <bold>(A)</bold> Effect of TPx protein on Treg cell differentiation; <bold>(B)</bold> Effect of TPx protein on Th17 cell differentiation; *<italic>P</italic> &lt; 0.05; **<italic>P</italic> &lt; 0.01; ns, no significant difference. The Treg/Th17 ratio was analyzed in Jurkat cells after treatment with TPx. Compared with the control cells, there was no significant difference after 24 h of TPx protein treatment. However, after 48 h and 72 h, TPx protein significantly induced an imbalance between Treg and Th17 cells. With increasing duration of stimulation, the ratio of Treg/Th17 cells exhibited an upward trend, resulting in a predominantly Treg cell-driven inhibitory immune response.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1612077-g001.tif">
<alt-text content-type="machine-generated">Flow cytometry plots compare control and TPx conditions at 24, 48, and 72 hours for CD4+ cells. The left panel shows CD127 versus CD25 with varying percentages: Control 4.25% to 3.74% and TPx 3.18% to 13.0%. The corresponding bar chart below displays CD4+CD25+CD127- Treg cells with increases across 24, 48, and 72 hours, notably higher in TPx compared to Control. The right panel shows IL-17A versus CD4 with percentages: Control 20.2% to 19.7% and TPx 20.7% to 17.5%. The corresponding bar chart below shows CD4+IL-17A+ Th17 cells decreasing at 48 and 72 hours, with the TPx group significantly lower than the Control. Statistical significance is indicated with asterisks.</alt-text>
</graphic></fig>
<p>Treg/Th17 ratio was analyzed in Jurkat cells after treatment with TPx. As shown in <xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref>, compared to the control cells, there was no significant difference after 24 h of TPx protein treatment. However, after 48 h and 72 h, TPx protein significantly induced an imbalance between Treg and Th17 cells. With increasing stimulation time, the ratio of Treg/Th17 cells exhibited an upward trend, resulting in a predominantly Treg cell-driven inhibitory immune response.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Effect of TPx protein on the balance of Treg/Th17 cells. The black dots represent the ratio of the CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>-</sup> Treg cell subset to the CD4<sup>+</sup>IL-17A<sup>+</sup> Th17 cell subset in the control cells at different time points; the blue squares represent the ratio of the CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>-</sup>Treg cell subset to the CD4<sup>+</sup>IL-17A<sup>+</sup> Th17 cell subset in the TPx-treated cells at different time points.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1612077-g002.tif">
<alt-text content-type="machine-generated">Scatter plot showing Treg/Th17 ratios over time at 24, 48, and 72 hours. Black circles represent the control group; blue squares represent the TPx group. The Treg/Th17 ratio for the TPx group increases over time.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Differential analysis of genes expression in human Jurkat T cells upon C. cellulose TPx protein treatment</title>
<sec id="s3_2_1">
<label>3.2.1</label>
<title>Differential expression gene analysis</title>
<p>As shown in the <xref ref-type="fig" rid="f3"><bold>Figures&#xa0;3</bold></xref> and <xref ref-type="fig" rid="f4"><bold>4</bold></xref>, statistical analysis revealed that compared to the 48 h control cells, a total of 108 genes with significant differential expression were identified in the 48 h TPx-treated cells. Among these, 64 genes were upregulated, including primarily SDC2, RPGRIP1, and AMY1B; 44 genes were downregulated, including primarily HAVCR1, NEFM, and LINC02603. Compared to the 72 h control cells, a total of 115 genes with significant differential expression were identified in the 72 h TPx-treated cells. Among these, 56 genes were upregulated, including primarily FSD2, CLDN11, and WNT5A; 59 genes were downregulated, including primarily ZNF280A, ACTN1-DT, and CTSE.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Bar graph of differentially expressed genes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1612077-g003.tif">
<alt-text content-type="machine-generated">Bar chart titled "Statistic of Differently Expressed Genes" showing gene expression differences. Two comparisons are displayed: "TPX48h-vs-Control48h" with 64 upregulated and 44 downregulated genes, and "TPX72h-vs-Control72h" with 56 upregulated and 59 downregulated genes. Red indicates upregulated and blue indicates downregulated.</alt-text>
</graphic></fig>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Volcano plot comparing differentially expressed genes between the TPx-treated cells and the control cells. <bold>(A)</bold> upon 48 h treatment; <bold>(B)</bold> upon 72 h treatment; Dots in the plot represent individual genes, arranged on the x-axis based on the logarithm of the expression ratio between groups and on the y-axis based on the statistical significance of the difference in expression between groups (FDR/adjusted p-value). The absolute value of the log<sub>2</sub> expression ratio of 1 (min. 2-fold higher gene expression in one or another group of samples) was taken as the significance threshold on the x-axis, and a -log<sub>10</sub> p-value of less than 0.05 (<italic>p</italic> &lt; 0.05) was set as the significance threshold on the y-axis. Genes without significant differences are shown in gray, while significantly differentially expressed genes are color-coded in red and blue. Specifically, red denotes upregulated genes and blue denotes downregulated genes. The greater the distance from the dashed line, the more pronounced the difference in gene expression between the two groups.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1612077-g004.tif">
<alt-text content-type="machine-generated">Two volcano plots labeled A and B compare gene expression changes. Plot A shows significant upregulated genes in red and downregulated in blue at 48 hours. Plot B presents similar data for 72 hours. Both plots display log2 fold change on the x-axis and -log10 p-value on the y-axis.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_2_2">
<label>3.2.2</label>
<title>GO functional annotation</title>
<p>As shown in the <xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5</bold></xref>, the GO terms enriched in the differential genes between the 48 h TPx-treated cells and the 48 h control cells mainly include: phagocytosis, extracellular matrix structural constituent, and positive regulation of mast cell activation. The GO terms enriched in the differential genes between the 72 h TPx-treated cells and the 72 h control cells mainly include: activation of GTPase activity, Wnt signaling pathway, cell polarity pathway, and formation of two-cell tight junctions. These findings indicate that TPx protein can induce changes in T cell immune responses, cell differentiation, and signaling molecules in Jurkat cells.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Top 30 enriched GO terms between the TPx-treated cells and the control cells. <bold>(A)</bold> Top 30 enriched GO terms between the 48 h TPx-treated cells and the 48 h control cells; <bold>(B)</bold> Top 30 enriched GO terms between the 72 h TPx-treated cells and the 48 h control cells; The horizontal axis represents -log<sub>10</sub> p-values, and the vertical axis represents enriched GO terms.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1612077-g005.tif">
<alt-text content-type="machine-generated">Bar charts comparing the top 30 GO terms between TPx and control at 48 hours (left) and 72 hours (right). Each panel categorizes terms into Biological Process, Cellular Component, and Molecular Function, represented in green, orange, and blue respectively. The x-axis shows the negative logarithm of the p-value, indicating significance levels.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_2_3">
<label>3.2.3</label>
<title>Enrichment analysis of KEGG signaling pathways</title>
<p>As shown in <xref ref-type="fig" rid="f6"><bold>Figures&#xa0;6A, B</bold></xref>, compared with the 48 h control cells, the 48 h TPx-treated cells experimental group were mainly enriched in upregulated signaling pathways including cell adhesion molecules, neuroactive ligand-receptor interaction, and histidine metabolism. The downregulated pathways primarily include Ras signaling pathway, spliceosome, and protein digestion and absorption. As shown in <xref ref-type="fig" rid="f6"><bold>Figures&#xa0;6C, D</bold></xref>, compared with the 72 h control cells, the 72 h TPx-treated cells were mainly enriched in upregulated signaling pathways such as the Hippo signaling pathway, cell adhesion molecules, and neuroactive ligand-receptor interaction. The downregulated pathways primarily include the HIF-1 signaling pathway, Ras signaling pathway, mitogen-activated protein kinase (MAPK) signaling pathway, and PI3K-Akt signaling pathway. The results indicate that these differentially expressed genes are primarily involved in processes such as the cell cycle, cellular biological responses, and T cell proliferation and differentiation.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Bubble plot comparing KEGG pathways between the TPx-treated cells and the control cells. <bold>(A)</bold> upon 48 h of TPx protein treatment (Up); <bold>(B)</bold> upon 48 h of TPx protein treatment (Down); <bold>(C)</bold> upon 72 h of TPx protein treatment (Up); <bold>(D)</bold> upon 72 h of TPx protein treatment (Down). Top 20 pathways are shown, with enrichment scores and p-values indicated by dot size and color.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1612077-g006.tif">
<alt-text content-type="machine-generated">Four-panel KEGG enrichment analysis chart shows top twenty pathways for different comparisons. Panel A displays upregulated pathways at forty-eight hours post-treatment. Key pathways include neuroactive ligand-receptor interaction and asthma. Panel B shows downregulated pathways for the same time, highlighting cell adhesion molecules and Ras signaling. Panel C focuses on upregulated pathways at seventy-two hours, emphasizing tight junction and Hippo signaling. Panel D illustrates downregulated pathways at seventy-two hours, noting peroxisome and lysosome involvement. Bubble size indicates the number of genes, with color denoting p-value significance.</alt-text>
</graphic></fig>
</sec>
<sec id="s3_2_4">
<label>3.2.4</label>
<title>GSEA enrichment analysis</title>
<p>To explore the signaling pathways through which the <italic>T. solium metacestode</italic> TPx protein affects the differentiation of Treg/Th17 cells, based on the KEGG database, further GSEA was performed for signaling pathway enrichment analysis on differential genes. As shown in <xref ref-type="fig" rid="f7"><bold>Figures&#xa0;7A, B</bold></xref>, compared with the 48 h control cells, the TGF-&#x3b2; signaling pathway and Th17 cell differentiation pathway were upregulated in the 48 h TPx-treated cells. As shown in <xref ref-type="fig" rid="f7"><bold>Figures&#xa0;7C, D</bold></xref>, compared with the 72 h control cells, the TGF-&#x3b2; signaling pathway was upregulated in the 72 h TPx-treated cells, while the Th17 cell differentiation pathway was downregulated.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Enrichment plot of GSEA pathways. <bold>(A)</bold> Enrichment plot of GSEA pathways for the TGF-&#x3b2; signaling pathway comparing the 48 h TPx-treated cells with the 48 h control cells; <bold>(B)</bold> Enrichment plot of GSEA pathways for Th17 cell differentiation comparing the 48 h TPx-treated cells with the 48 h control cells; <bold>(C)</bold> Enrichment plot of GSEA pathways for TGF-&#x3b2; signaling pathway comparing the 72 h TPx-treated cells with the 72 h control cells; <bold>(D)</bold> Enrichment plot of GSEA pathways for Th17 cell differentiation comparing the 72h TPx-treated cells with the 72 h control cells; the figure is divided into four parts from top to bottom: &#x2460; Distribution of Enrichment Scores (ES), where the green line represents the distribution of ES for all genes. The peak of this curve corresponds to the absolute maximum ES value for the gene set. When ES &gt; 0, core genes are on the left side of the peak; when ES &lt; 0, they are on the right side. &#x2461; Gene Distribution Plot, where vertical lines represent the positions of genes in the entire ranking. &#x2462; Colorbar, which is the color mapping of the ranking matrix. Positive values correspond to red, where larger values are deeper red, and negative values correspond to blue. Values closer to 0 are closer to white. &#x2463; Distribution Plot of the ranking matrix, showing fold change, signal-to-noise ratio, etc. <bold>(A)</bold> GSEA pathway enrichment plot for the TGF-&#x3b2; signaling pathway; <bold>(B)</bold> GSEA pathway enrichment plot for Th17 cell differentiation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1612077-g007.tif">
<alt-text content-type="machine-generated">Four panels display enrichment plots. Panel A shows TGF-beta signaling pathway at 48 hours with an enrichment score (ES) of 0.315. Panel B shows Th17 cell differentiation at 48 hours with ES of 0.288. Panel C shows TGF-beta signaling pathway at 72 hours with ES of 0.293. Panel D shows Th17 cell differentiation at 72 hours with ES of -0.228. Each plot includes a running ES line, ranking metrics, and color-coded signals.</alt-text>
</graphic></fig>
<p>Further, 20 differentially expressed genes associated with the TGF-&#x3b2; signaling pathway and Treg/Th17 cell differentiation were selected to construct a heatmap of differential genes, comparing the differences between the 0 h control cells, 48 h TPx-treated cells, and 72 h TPx-treated cells. As shown in <xref ref-type="fig" rid="f8"><bold>Figure&#xa0;8</bold></xref>, compared with the 0 h control cells, the relative expression levels of differentially expressed genes such as <italic>TGF-&#x3b2;</italic>, <italic>TGF-&#x3b2;R1</italic>, <italic>TGF-&#x3b2;R2</italic>, and <italic>SMAD3</italic> were higher in the 48 h and 72 h TPx-treated cells, while the change in <italic>SMAD2</italic> was not significant. Notably, with increasing exposure time to <italic>T. solium metacestode</italic> TPx protein, the relative expression levels of the differential genes <italic>TGF-&#x3b2;, TGF-&#x3b2;R1</italic>, and <italic>SMAD3</italic> showed an increasing trend. Compared with the 0 h control cells, the relative expression levels of differential genes such as <italic>SMAD4, FOS</italic>, and <italic>RUNX1</italic> were lower in the 48 h and 72 h TPx-treated cells. No significant changes in <italic>RORC(&#x3b3;t)</italic> and <italic>FOXP3</italic> were observed in the 48 h TPx-treated cells; however, both genes showed lower relative expression levels in the 72 h TPx-treated cells. Thus, TPx protein treatment of Jurkat cells for 48 h and 72 h can upregulate the TGF-&#x3b2; signaling pathway in Jurkat cells and may further regulate Treg/Th17 cell differentiation through transcription factors such as TGF-&#x3b2;, TGF-&#x3b2;R1, SMAD3, FOXP3, and RORC(&#x3b3;t).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Heatmap of differentially expressed genes related to the TGF-&#x3b2; signaling pathway and Treg, Th17 cell differentiation. &#x201c;Jurkat_0h&#x201d; represents the 0 h control cells, &#x201c;Jurkat_48h&#x201d; represents the 48 h TPx-treated cells, and &#x201c;Jurkat_72h&#x201d; represents the 72 h TPx-treated cells. In the image, red color indicates genes encoding proteins with relatively high expression, while blue color indicates genes encoding proteins with relatively low expression.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1612077-g008.tif">
<alt-text content-type="machine-generated">Heatmap of differentially expressed genes related to the TGF-β signaling pathway and Treg/Th17 cell differentiation. "Jurkat0h" represents the 0 h control cells, "Jurkat48h" represents the 48 h TPx-treated cells, and "Jurkat_72h" represents the 72 h TPx-treated cells. Red indicates genes with relatively high expression; blue indicates genes with relatively low expression.</alt-text>
</graphic></fig>
</sec>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>The expression levels of proteins and phosphorylated proteins associated with Treg and Th17 cell differentiation that are involved in the TGF/Smad signaling pathway</title>
<p>The differential transcriptomic results for Jurkat cells induced by TPx protein indicate that key proteins such as TGF-&#x3b2;1, TGF-&#x3b2;R2, Smad4, Smad3, FOXP3, and RORC(&#x3b3;t) in the TGF-&#x3b2;/Smad signaling pathway may be involved in the processes that lead to Treg/Th17 cell imbalance. Therefore, western blot analysis was used to detect the expression levels of these proteins during the dynamic changes in Treg/Th17 cell balance.</p>
<p>The results are shown in <xref ref-type="fig" rid="f9"><bold>Figure&#xa0;9</bold></xref>. Compared with those in the control cells, the protein expression levels of TGF-&#x3b2;1, TGF-&#x3b2;R2, and p-Smad3 were significantly increased after 48 h and 72 h of TPx protein induction (<italic>P</italic> &lt; 0.05). After 48 h of TPx protein induction, Smad4 protein expression showed an upregulated trend, but the difference was not significant (<italic>P</italic> &gt; 0.05). Compared with the 72 h control cells, there was no significant change in Smad4 protein expression after 72 h of induction (<italic>P</italic> &gt; 0.05).</p>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>Effect of TPx protein on the expression of proteins related to the TGF-&#x3b2;/Smad signaling pathway (n = 3, x &#xb1; S). <bold>(A)</bold> TGF-&#x3b2;1/GAPDH ratio; <bold>(B)</bold> TGF-&#x3b2;R2/GAPDH ratio; <bold>(C)</bold> p-Smad3/Smad3 ratio; <bold>(D)</bold> Smad4/GAPDH ratio; <bold>(E)</bold> Foxp3/GAPDH ratio; <bold>(F)</bold> RORC(&#x3b3;t)/GAPDH ratio; * means <italic>P</italic> &lt; 0.05; ** means <italic>P</italic> &lt; 0.01; ns means no significant difference.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-17-1612077-g009.tif">
<alt-text content-type="machine-generated">Western blot analysis showing the effect of TPx protein on TGF-β/Smad signaling pathway-related protein expression at 48 and 72 hours. The expression of TGF-β1, TGF-βR2, the p-Smad3/Smad3 ratio, and Foxp3 is upregulated in the TPx group at both time points (Panels A-C, E). Smad4 expression shows no significant difference (Panel D). RORC(γt) expression is upregulated at 72 hours (Panel F). Statistical significance is indicated (Statistical significance is indicated with asterisks; ns, not significant).</alt-text>
</graphic></fig>
<p>Compared with those in the control cells, the FOXP3 protein expression levels were significantly increased after 48 h and 72 h of TPx protein induction (<italic>P</italic> &lt; 0.05). After 48 h of TPx protein induction, the change in RORC(&#x3b3;t) protein levels was not significant (<italic>P</italic> &gt; 0.05). However, the RORC(&#x3b3;t) protein expression level was significantly decreased after 72 h of induction (<italic>P</italic> &lt; 0.05).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Cysticercosis poses a greater threat than <italic>T. solium</italic> infection, and is primarily distributed in low- and middle-income developing countries. However, with globalization, some developed countries have also gradually reported imported cases (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). Advances in molecular biology and immunology have increased our understanding of immune defense responses and immunopathological mechanisms related to parasitic infections in recent years. After invading the host, parasites avoid elimination by using various mechanisms to evade the host&#x2019;s innate immune system. However, the host can suppress parasitic growth by inducing antigen-specific T cell differentiation into effector cells (<xref ref-type="bibr" rid="B22">22</xref>). For parasites to survive, they must evade this acquired immune defense of the host (<xref ref-type="bibr" rid="B23">23</xref>). <italic>T. solium metacestode</italic> can induce varying degrees of immune responses in the host at different infection stages, with the parasitic location and infection severity closely related to changes in T lymphocyte subsets (<xref ref-type="bibr" rid="B24">24</xref>).</p>
<p>Treg cells are significantly increased in the peripheral blood and cerebrospinal fluid of patients with NCC, leading to immune dysfunction characterized by an immunosuppressive state (<xref ref-type="bibr" rid="B25">25</xref>&#x2013;<xref ref-type="bibr" rid="B27">27</xref>). In this study, we observed that <italic>T. solium metacestode</italic> TPx protein can inhibit the differentiation of CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>&#x2212;</sup> Treg cells at 24 hours, with no significant effect on the differentiation of CD4<sup>+</sup>IL-17A<sup>+</sup> Th17 cells, resulting in no notable difference in the Treg/Th17 cell ratio relative to the control cells. However, at 48 and 72 hours, TPx protein significantly induced the differentiation of CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>&#x2212;</sup> Treg cells and inhibited the differentiation of CD4<sup>+</sup>IL-17A<sup>+</sup> Th17 cells, leading to an imbalance between Treg and Th17 cells. This imbalance manifests as an inhibitory immune response predominantly involving Treg cells, which may represent a true &#x201c;window&#x201d; that favors the evasion of the host&#x2019;s immune response by <italic>T. solium metacestode</italic> during the later stages of infection. Through GSEA, we discovered that <italic>T. solium metacestode</italic> TPx protein can activate the TGF-&#x3b2;/Smad signaling pathway in human Jurkat T lymphocytes at both 48 h and 72 h of exposure, and multiple related transcription factors such as TGF-&#x3b2;, TGF-&#x3b2;R1, TGF-&#x3b2;R2, and Smad3 were upregulated under the influence of TPx protein. These findings collectively suggest that the TGF-&#x3b2;/Smad signaling pathway may be a key pathway through which the TPx protein of <italic>T. solium metacestode</italic> regulates host immune responses.</p>
<p>In this study, it was found that <italic>T. solium metacestode</italic> TPx protein can upregulate the expression of TGF-&#x3b2;1, TGF&#x3b2;R2, and p-Smad3 proteins at 48 h and 72 h, activating the TGF-&#x3b2;/Smad signaling pathway. Additionally, the expression of the key transcription factor Foxp3, which regulates Treg cell differentiation, showed an upward trend at both 48 h and 72 h, while the expression of RORC (&#x3b3;t), a key transcription factor for Th17 cell differentiation, showed a downward trend at 72 h. This suggests that <italic>T. solium metacestode</italic> TPx protein can regulate Foxp3 expression and induce Treg cell differentiation by activating the TGF-&#x3b2;/Smad signaling pathway at 48 h and 72 h. With increased duration of stimulation, its inhibitory effect on Th17 cells gradually increases, significantly suppressing Th17 cell differentiation at 72 h. This induces a reversal in the Treg/Th17 cell ratio imbalance, leading to a predominance of Treg cells. This shift benefits <italic>T. solium metacestode</italic> by aiding its evasion of the host&#x2019;s immune response in the later stages of infection, potentially resulting in the parasite&#x2019;s escape from immune attack and establishment of chronic infection. In the present study, we observed a concurrent downregulation of both Foxp3 and RORC (&#x3b3;t) mRNA expression at the transcriptome level; however, at the protein level, Foxp3 expression was notably upregulated. This seemingly paradoxical phenomenon may precisely reveal a sophisticated and complex mechanism through which the TPx protein regulates the host immune response. The transient decrease in Foxp3 mRNA coupled with the progressive accumulation of its protein reflects a dynamic and asynchronous regulatory phase during Treg cell differentiation. The expression of key transcription factors such as Foxp3 is subject to stringent, multi-layered regulation. Although its mRNA level decreases, its protein translation efficiency, stability, or post-translational modifications (e.g., phosphorylation, ubiquitination) may be significantly influenced by the TPx protein. For instance, the TPx protein may stabilize Foxp3 protein or inhibit its degradation via the ubiquitin-proteasome pathway, potentially through the TGF-&#x3b2;/Smad signaling axis or other unidentified pathways, thereby leading to its accumulation at the protein level despite reduced mRNA expression. In this study, we also found that <italic>T. solium</italic> metacestode TPx protein can downregulate the expression of Runt-related transcription factor 1 (RUNX1) at 48 h and 72 h. RUNX1 can cooperate with Foxp3 to promote Treg cell differentiation and also bind to ROR&#x3b3;t to drive Th17 cell differentiation (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). This suggests that downregulating RUNX1 may favor steering the differentiation program toward a Foxp3-dominated Treg pathway rather than an ROR&#x3b3;t-dominated Th17 pathway. This provides clear direction and rationale for our subsequent investigations into the underlying mechanisms.</p>
<p>During various stages of parasitic infection, T cell immune response-related signaling pathways can participate in cell differentiation, inflammation, and immune response through interactions among signaling molecules. Transcriptomic analysis in this study revealed that <italic>T. solium metacestode</italic> TPx protein induces downregulation of the MAPK signaling pathway and the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway in Jurkat cells. The MAPK pathway mainly comprises four sub-pathways: extracellular signal-regulated kinase (ERK) 1/2, c-Jun N-terminal kinase (JNK), p38 MAPK, and ERK5 (<xref ref-type="bibr" rid="B30">30</xref>). Phosphorylation of p38 MAPK, JNK, and ERK can increase the production of inflammatory factors, thereby exacerbating the inflammatory response (<xref ref-type="bibr" rid="B31">31</xref>). Mitogen-activated protein kinase (MEK) is a specific activator of ERK. Studies have shown that in mouse splenic CD4<sup>+</sup> T cells, blocking the MAPK/ERK signaling pathway with MEK siRNA increases TGF-&#x3b2;-induced Foxp3 expression and enhances Treg cell differentiation, while reducing ROR&#x3b3;t expression and Th17 cell differentiation. This suggests that the MAPK/ERK signaling pathway promotes differentiation of CD4<sup>+</sup> T cells into Th17 cells while inhibiting Treg cell differentiation (<xref ref-type="bibr" rid="B32">32</xref>). The PI3K/AKT signaling pathway plays a crucial role in inflammatory immune cascades. Inhibition of the PI3K/AKT signaling pathway can impair the inflammatory response. Studies indicate that extracellular vesicles (EVs) from <italic>T. solium metacestode</italic> contain metabolites that negatively regulate the PI3K/AKT signaling pathway, promoting macrophage apoptosis. This may be a significant mechanism by which <italic>T. solium metacestode</italic> exerts immunosuppressive effects and causes asymptomatic infection in the early stages of NCC (<xref ref-type="bibr" rid="B33">33</xref>).</p>
<p>In summary, the results of this study indicate that the TPx protein can inhibit Treg cell differentiation at 24 hours, with no significant effect on Th17 cell differentiation. However, after 48 and 72 hours of culture, it can induce Treg cell differentiation, inhibit Th17 cell differentiation, and induce Treg/Th17 cell imbalance, resulting in a suppressive immune response dominated by Treg cells. Transcriptomic analysis of Jurkat cells before and after exposure to <italic>T. solium metacestode</italic> TPx protein revealed that the TGF-&#x3b2;/Smad signaling pathway can be activated at both 48 and 72 hours. Western blotting confirmed that the expression of key transcription factors TGF-&#x3b2;1, TGF-&#x3b2;R2, and p-Smad3 proteins involved in Treg and Th17 cell differentiation significantly increased at 48 and 72 hours, indicating that the TGF-&#x3b2;/Smad signaling pathway can be activated by the TPx protein. The expression level of Foxp3, a key transcription factor for Treg cell differentiation, significantly increased after 48 and 72 hours of induction, while the expression level of RORC(&#x3b3;t), a transcription factor related to Th17 cell differentiation, significantly decreased after 72 hours of induction but showed no significant change at 48 hours. This suggests that <italic>T. solium metacestode</italic> TPx protein may further regulate the expression levels of Foxp3 and RORC(&#x3b3;t) through the TGF-&#x3b2;/Smad signaling pathway, thereby inducing host Treg/Th17 cell imbalance. Taken together, these findings suggest that <italic>T. solium metacestode</italic> TPx protein may primarily induce host Treg/Th17 cell imbalance through the TGF-&#x3b2;/Smad signaling pathway, providing important experimental data for further verifying the role of the TGF-&#x3b2;/Smad signaling pathway in the immune regulation of cysticercosis. The findings offer valuable insights to elucidate the molecular mechanisms involved in the pathogenesis of cysticercosis and provide new strategies for the prevention and treatment of this disease.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>The <italic>T. solium metacestode</italic> TPx protein induces early (24 h) reduction in Treg cell differentiation and late (48 h, 72 h) Treg/Th17 cell imbalance in human Jurkat cells, leading to an inhibitory immune response predominantly involving Treg cells. The dynamic immunodifferentiatory mechanism underlying this phenomenon is associated with the TGF-&#x3b2;/Smad signaling pathway. <italic>T. solium metacestode</italic> TPx protein can activate this pathway to further regulate the expression levels of key transcription factors Foxp3 and RORC(&#x3b3;t) involved in Treg and Th17 cell differentiation, thereby affecting the balance between Treg and Th17 cells.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: <uri xlink:href="https://data.4tu.nl/private_datasets/wJMc9JOSVpHcNsBCKFajC_BTBaRlg--YM5fy-CrEnUs">https://data.4tu.nl/private_datasets/wJMc9JOSVpHcNsBCKFajC_BTBaRlg--YM5fy-CrEnUs</uri>.</p></sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p></sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>XS: Data curation, Conceptualization, Investigation, Writing &#x2013; review &amp; editing, Writing &#x2013; original draft. QM: Writing &#x2013; review &amp; editing, Conceptualization. BZ: Resources, Writing &#x2013; review &amp; editing, Funding acquisition, Conceptualization.</p></sec>
<ack>
<title>Acknowledgments</title>
<p>We thank Shanghai OE Biotech Co., Ltd. (Shanghai, China) for supporting differential transcriptomics analysis.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>FAO/WHO</collab>
</person-group>. <source>Multicriteria-based Ranking for Risk Management of Food-Borne Parasites</source>. <publisher-loc>Rome, Italy</publisher-loc>: 
<publisher-name>Food and Agriculture Organization of the United Nations/World Health Organization</publisher-name> (<year>2014</year>). Microbiological Risk Assessment Series No. 23.
</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Minani</surname> <given-names>S</given-names></name>
<name><surname>Dorny</surname> <given-names>P</given-names></name>
<name><surname>Trevisan</surname> <given-names>C</given-names></name>
</person-group>. 
<article-title>Prevalence and risk assessment of porcine cysticercosis in Ngozi province, Burundi</article-title>. <source>Vet Parasitol Reg Stud Rep</source>. (<year>2021</year>) <volume>23</volume>:<elocation-id>100514</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vprsr.2020.100514</pub-id>, PMID: <pub-id pub-id-type="pmid">33678369</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bouteille</surname> <given-names>B</given-names></name>
</person-group>. 
<article-title>Epidemiology of cysticercosis and neurocysticercosis</article-title>. <source>Med Sant&#xe9; Trop</source>. (<year>2014</year>) <volume>24</volume>:<page-range>367&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1684/mst.2014.0378</pub-id>, PMID: <pub-id pub-id-type="pmid">25296005</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kaur</surname> <given-names>R</given-names></name>
<name><surname>Arora</surname> <given-names>N</given-names></name>
<name><surname>Rawat</surname> <given-names>SS</given-names></name>
<name><surname>Keshri</surname> <given-names>AK</given-names></name>
<name><surname>Sharma</surname> <given-names>SR</given-names></name>
<name><surname>Mishra</surname> <given-names>A</given-names></name>
<etal/>
</person-group>. 
<article-title>Vaccine for a neglected tropical disease <italic>Taenia solium</italic> cysticercosis: fight for eradication against all odds</article-title>. <source>Expert Rev Vaccines</source>. (<year>2021</year>) <volume>20</volume>:<page-range>1447&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/14760584.2021.1967750</pub-id>, PMID: <pub-id pub-id-type="pmid">34379534</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname> <given-names>Y</given-names></name>
<name><surname>Luo</surname> <given-names>B</given-names></name>
<name><surname>Liu</surname> <given-names>MC</given-names></name>
<name><surname>OuYang</surname> <given-names>RH</given-names></name>
<name><surname>Fan</surname> <given-names>XM</given-names></name>
<name><surname>Jiang</surname> <given-names>N</given-names></name>
<etal/>
</person-group>. 
<article-title>Analysis of immune response in BALB/c mice immunized with recombinant plasmids pMZ-X3-Ts14-3-3.3 and pMZ-X3-sp-Ts14-3-3.3 of <italic>Taenia solium</italic></article-title>. <source>Acta Trop</source>. (<year>2022</year>) <volume>232</volume>:<elocation-id>106517</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.actatropica.2022.106517</pub-id>, PMID: <pub-id pub-id-type="pmid">35595093</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yang</surname> <given-names>YY</given-names></name>
<name><surname>Yang</surname> <given-names>JQ</given-names></name>
</person-group>. 
<article-title>Immunomodulatory effects of Treg and Th17 cells in parasitic infectionsand hygiene hypothesis</article-title>. <source>Chin J Schistosomiasis Control</source>. (<year>2017</year>) <volume>29</volume>:<page-range>116&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.16250/j.32.1374.2016139</pub-id>, PMID: <pub-id pub-id-type="pmid">29469406</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hou</surname> <given-names>X</given-names></name>
<name><surname>Lei</surname> <given-names>JH</given-names></name>
<name><surname>Ding</surname> <given-names>JY</given-names></name>
</person-group>. 
<article-title>Treg/Th17 cells balance immunity to parasitic infections</article-title>. <source>Military Med J South China</source>. (<year>2017</year>) <volume>31</volume>:<page-range>715&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.13730/j.issn.1009-2595.2017.10.019</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>He</surname> <given-names>W</given-names></name>
<name><surname>Mu</surname> <given-names>Q</given-names></name>
<name><surname>Li</surname> <given-names>L</given-names></name>
<name><surname>Sun</surname> <given-names>X</given-names></name>
<name><surname>Fan</surname> <given-names>X</given-names></name>
<name><surname>Yang</surname> <given-names>F</given-names></name>
<etal/>
</person-group>. 
<article-title>Effects of <italic>Cysticercus cellulosae</italic> excretory-secretory antigens on the TGF-&#x3b2; signaling pathway and Th17 cell differentiation in piglets, a Proteomic Analysis</article-title>. <source>Microorganisms</source>. (<year>2023</year>) <volume>11</volume>:<fpage>601</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms11030601</pub-id>, PMID: <pub-id pub-id-type="pmid">36985175</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Verrecchia</surname> <given-names>F</given-names></name>
<name><surname>Mauviel</surname> <given-names>A</given-names></name>
</person-group>. 
<article-title>Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation</article-title>. <source>J Invest Dermatol</source>. (<year>2002</year>) <volume>118</volume>:<page-range>211&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1523-1747.2002.01641.x</pub-id>, PMID: <pub-id pub-id-type="pmid">11841535</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wrighton</surname> <given-names>KH</given-names></name>
<name><surname>Lin</surname> <given-names>X</given-names></name>
<name><surname>Feng</surname> <given-names>XH</given-names></name>
</person-group>. 
<article-title>Phospho-control of TGF-beta superfamily signaling</article-title>. <source>Cell Res</source>. (<year>2009</year>) <volume>19</volume>:<fpage>8</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cr.2008.327</pub-id>, PMID: <pub-id pub-id-type="pmid">19114991</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>McKarns</surname> <given-names>SC</given-names></name>
<name><surname>Schwartz</surname> <given-names>RH</given-names></name>
</person-group>. 
<article-title>Distinct effects of TGF-&#x3b2;1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3</article-title>. <source>J Immunol</source>. (<year>2005</year>) <volume>174</volume>:<page-range>2071&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.174.4.2071</pub-id>, PMID: <pub-id pub-id-type="pmid">15699137</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kleiter</surname> <given-names>I</given-names></name>
<name><surname>Song</surname> <given-names>J</given-names></name>
<name><surname>Lukas</surname> <given-names>D</given-names></name>
<name><surname>Hasan</surname> <given-names>M</given-names></name>
<name><surname>Neumann</surname> <given-names>B</given-names></name>
<name><surname>Croxford</surname> <given-names>AL</given-names></name>
<etal/>
</person-group>. 
<article-title>Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis</article-title>. <source>Brain</source>. (<year>2010</year>) <volume>133</volume>:<page-range>1067&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/brain/awq039</pub-id>, PMID: <pub-id pub-id-type="pmid">20354004</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname> <given-names>S</given-names></name>
</person-group>. 
<article-title>The role of transforming growth factor &#x3b2; in T helper 17 differentiation</article-title>. <source>Immunology</source>. (<year>2018</year>) <volume>155</volume>:<fpage>24</fpage>&#x2013;<lpage>35</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imm.12938</pub-id>, PMID: <pub-id pub-id-type="pmid">29682722</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>F</given-names></name>
<name><surname>Yang</surname> <given-names>Y</given-names></name>
<name><surname>Li</surname> <given-names>Z</given-names></name>
<name><surname>Wang</surname> <given-names>Y</given-names></name>
<name><surname>Zhang</surname> <given-names>Z</given-names></name>
<name><surname>Zhang</surname> <given-names>W</given-names></name>
<etal/>
</person-group>. 
<article-title>Mannan-binding lectin regulates the Th17/Treg axis through JAK/STAT and TGF-&#x3b2;/SMAD signaling against&#xa0;Candida albicans&#xa0;infection</article-title>. <source>J Inflamm Res</source>. (<year>2022</year>) <volume>15</volume>:<page-range>1797&#x2013;810</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/JIR.S344489</pub-id>, PMID: <pub-id pub-id-type="pmid">35300210</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>He</surname> <given-names>W</given-names></name>
<name><surname>Sun</surname> <given-names>X</given-names></name>
<name><surname>Luo</surname> <given-names>B</given-names></name>
<name><surname>Liu</surname> <given-names>M</given-names></name>
<name><surname>Li</surname> <given-names>L</given-names></name>
<name><surname>Fan</surname> <given-names>X</given-names></name>
<etal/>
</person-group>. 
<article-title>Regulation of piglet T-cell immune responses by thioredoxin peroxidase from <italic>Cysticercus cellulosae</italic> excretory-secretory antigens</article-title>. <source>Front Microbiol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>1019810</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2022.1019810</pub-id>, PMID: <pub-id pub-id-type="pmid">36466695</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname> <given-names>L</given-names></name>
<name><surname>He</surname> <given-names>W</given-names></name>
<name><surname>Fan</surname> <given-names>X</given-names></name>
<name><surname>Liu</surname> <given-names>M</given-names></name>
<name><surname>Luo</surname> <given-names>B</given-names></name>
<name><surname>Yang</surname> <given-names>F</given-names></name>
<etal/>
</person-group>. 
<article-title>Proteomic analysis of <italic>Taenia solium</italic> cysticercus and adult stages</article-title>. <source>Front Vet Sci</source>. (<year>2023</year>) <volume>9</volume>:<elocation-id>934197</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fvets.2022.934197</pub-id>, PMID: <pub-id pub-id-type="pmid">36699330</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yin</surname> <given-names>C</given-names></name>
<name><surname>Luo</surname> <given-names>XN</given-names></name>
<name><surname>Wang</surname> <given-names>S</given-names></name>
<name><surname>Chen</surname> <given-names>GL</given-names></name>
<name><surname>Zeng</surname> <given-names>QY</given-names></name>
<name><surname>Cai</surname> <given-names>XP</given-names></name>
</person-group>. 
<article-title>Prokaryotic Expression and Biological Properties of Thioredoxin Peroxidase from <italic>Taenia solium</italic></article-title>. <source>Chin J Anim Vet Sci</source>. (<year>2014</year>) <volume>45</volume>:<page-range>1512&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.11843/j.issn.0366-6964.2014.09.018</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname> <given-names>JL</given-names></name>
<name><surname>Nong</surname> <given-names>GM</given-names></name>
</person-group>. 
<article-title>Advances in application of Jurkat cell model in research on infectious diseases</article-title>. <source>Zhongguo Dang Dai Er Ke Za Zhi</source>. (<year>2018</year>) <volume>20</volume>:<page-range>236&#x2013;42</page-range>. doi: <pub-id pub-id-type="doi">10.7499/j.issn.1008-8830.2018.03.014</pub-id>, PMID: <pub-id pub-id-type="pmid">29530126</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Luo</surname> <given-names>B</given-names></name>
<name><surname>Gou</surname> <given-names>YT</given-names></name>
<name><surname>Cui</surname> <given-names>HL</given-names></name>
<name><surname>Yin</surname> <given-names>CZ</given-names></name>
<name><surname>Sun</surname> <given-names>D</given-names></name>
<name><surname>Li</surname> <given-names>D</given-names></name>
<etal/>
</person-group>. 
<article-title>The C/EBP&#x3b2;-SESN2 axis promotes M2b macrophage polarization induced by T.cp-MIF to suppress inflammation in <italic>Thelazia Callipaeda</italic> infection</article-title>. <source>Inflammation</source>. (<year>2025</year>) <volume>48</volume>:<page-range>1245&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10753-024-02114-2</pub-id>, PMID: <pub-id pub-id-type="pmid">39215929</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>IIto</surname> <given-names>A</given-names></name>
<name><surname>Yanagida</surname> <given-names>T</given-names></name>
<name><surname>Nakao</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Recent advances and perspectives in molecular epidemiology of <italic>Taenia solium</italic> cysticercosis</article-title>. <source>Infect Genet Evol</source>. (<year>2016</year>) <volume>40</volume>:<page-range>357&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.meegid.2015.06.022</pub-id>, PMID: <pub-id pub-id-type="pmid">26112071</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>DeCoster</surname> <given-names>T</given-names></name>
<name><surname>Van Damme</surname> <given-names>I</given-names></name>
<name><surname>Baauw</surname> <given-names>J</given-names></name>
<name><surname>Gabri&#xeb;l</surname> <given-names>S</given-names></name>
</person-group>. 
<article-title>Recent advancements in the control of <italic>Taenia solium</italic>: A systematic review</article-title>. <source>Food Waterborne Parasitol</source>. (<year>2018</year>) <volume>13</volume>:<elocation-id>e00030</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fawpar.2018.e00030</pub-id>, PMID: <pub-id pub-id-type="pmid">32095601</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Maizels</surname> <given-names>RM</given-names></name>
</person-group>. 
<article-title>Parasite immunomodulation and polymorphisms of the immune system</article-title>. <source>J Biol</source>. (<year>2009</year>) <volume>8</volume>:<fpage>62</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/jbiol166</pub-id>, PMID: <pub-id pub-id-type="pmid">19664200</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schmid-Hempel</surname> <given-names>P</given-names></name>
</person-group>. 
<article-title>Parasite immune evasion: a momentous molecular war</article-title>. <source>Trends Ecol Evol</source>. (<year>2008</year>) <volume>23</volume>:<page-range>318&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tree.2008.02.011</pub-id>, PMID: <pub-id pub-id-type="pmid">18439709</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fan</surname> <given-names>XM</given-names></name>
<name><surname>Zhou</surname> <given-names>BY</given-names></name>
</person-group>. 
<article-title>T lymphocytes are involved in the research progress of immune regulation of cysticercosis</article-title>. <source>Chin J Endemiol</source>. (<year>2021</year>) <volume>40</volume>:<page-range>164&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3760/cma.j.cn231583-20200115-00014</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Adalid-Peralta</surname> <given-names>L</given-names></name>
<name><surname>Fleury</surname> <given-names>A</given-names></name>
<name><surname>Garc&#xed;a-Ibarra</surname> <given-names>TM</given-names></name>
<name><surname>Hern&#xe1;ndez</surname> <given-names>M</given-names></name>
<name><surname>Parkhouse</surname> <given-names>M</given-names></name>
<name><surname>Crisp&#xed;n</surname> <given-names>JC</given-names></name>
<etal/>
</person-group>. 
<article-title>Human neurocysticercosis: <italic>in vivo</italic> expansion of peripheral regulatory T cells and their recruitment in the central nervous system</article-title>. <source>J Parasitol</source>. (<year>2012</year>) <volume>98</volume>:<page-range>142&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1645/GE-2839.1</pub-id>, PMID: <pub-id pub-id-type="pmid">21955298</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Arce-Sillas</surname> <given-names>A</given-names></name>
<name><surname>&#xc1;lvarez-Luqu&#xed;n</surname> <given-names>DD</given-names></name>
<name><surname>C&#xe1;rdenas</surname> <given-names>G</given-names></name>
<name><surname>Casanova-Hern&#xe1;ndez</surname> <given-names>D</given-names></name>
<name><surname>Fragoso</surname> <given-names>G</given-names></name>
<name><surname>Hern&#xe1;ndez</surname> <given-names>M</given-names></name>
<etal/>
</person-group>. 
<article-title>Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis</article-title>. <source>Clin Exp Immunol</source>. (<year>2016</year>) <volume>183</volume>:<page-range>271&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cei.12709</pub-id>, PMID: <pub-id pub-id-type="pmid">26391104</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Arce-Sillas</surname> <given-names>A</given-names></name>
<name><surname>C&#xe1;rdenas</surname> <given-names>G</given-names></name>
<name><surname>&#xc1;lvarez-Luqu&#xed;n</surname> <given-names>D</given-names></name>
<name><surname>Hernandez</surname> <given-names>M</given-names></name>
<name><surname>Del Rey</surname> <given-names>A</given-names></name>
<name><surname>Besedovsky</surname> <given-names>H</given-names></name>
<etal/>
</person-group>. 
<article-title>Treatment-resistant human extraparenchymal neurocysticercosis: an immune-inflammatory approach to cysticidal treatment outcome</article-title>. <source>Neuroimmunomodulation</source>. (<year>2018</year>) <volume>25</volume>:<page-range>103&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000491394</pub-id>, PMID: <pub-id pub-id-type="pmid">30041237</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ono</surname> <given-names>M</given-names></name>
</person-group>. 
<article-title>Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes</article-title>. <source>Immunology</source>. (<year>2020</year>) <volume>160</volume>:<fpage>24</fpage>&#x2013;<lpage>37</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imm.13206</pub-id>, PMID: <pub-id pub-id-type="pmid">32022254</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>lnaenaey</surname> <given-names>WA</given-names></name>
<name><surname>Omar</surname> <given-names>OM</given-names></name>
<name><surname>Aboelwafa</surname> <given-names>RA</given-names></name>
</person-group>. 
<article-title>Increased expression of IL-17A and IL-17F is correlated with RUNX1 and ROR&#x3b3;T in pediatric patients with primary immune thrombocytopenia</article-title>. <source>J Pediatr Hematol Oncol</source>. (<year>2021</year>) <volume>43</volume>:<page-range>e320&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MPH.0000000000002108</pub-id>, PMID: <pub-id pub-id-type="pmid">33633027</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ozawa</surname> <given-names>S</given-names></name>
<name><surname>Ito</surname> <given-names>S</given-names></name>
<name><surname>Kato</surname> <given-names>Y</given-names></name>
<name><surname>Kubota</surname> <given-names>E</given-names></name>
<name><surname>Hata</surname> <given-names>R</given-names></name>
</person-group>. 
<article-title>Human p38 delta MAP kinase mediates UV irradiation induced up-regulation of the gene expression of chemokine BRAK/CXCL14</article-title>. <source>Biochem Biophys Res Commun</source>. (<year>2010</year>) <volume>396</volume>:<page-range>1060&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2010.05.072</pub-id>, PMID: <pub-id pub-id-type="pmid">20478268</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>Y</given-names></name>
<name><surname>Zhang</surname> <given-names>P</given-names></name>
<name><surname>Zhang</surname> <given-names>J</given-names></name>
<name><surname>Hong</surname> <given-names>T</given-names></name>
</person-group>. 
<article-title>Inhibitory effect of bisdemethoxycurcumin on DNCB-induced atopic dermatitis in mice</article-title>. <source>Molecules</source>. (<year>2022</year>) <volume>28</volume>:<elocation-id>293</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules28010293</pub-id>, PMID: <pub-id pub-id-type="pmid">36615486</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>H</given-names></name>
<name><surname>Yao</surname> <given-names>S</given-names></name>
<name><surname>Dann</surname> <given-names>SM</given-names></name>
<name><surname>Qin</surname> <given-names>H</given-names></name>
<name><surname>Elson</surname> <given-names>CO</given-names></name>
<name><surname>Cong</surname> <given-names>Y</given-names></name>
</person-group>. 
<article-title>ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis</article-title>. <source>Eur J Immunol</source>. (<year>2013</year>) <volume>43</volume>:<page-range>1716&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.201242889</pub-id>, PMID: <pub-id pub-id-type="pmid">23620016</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rawat</surname> <given-names>SS</given-names></name>
<name><surname>Keshri</surname> <given-names>AK</given-names></name>
<name><surname>Arora</surname> <given-names>N</given-names></name>
<name><surname>Kaur</surname> <given-names>R</given-names></name>
<name><surname>Mishra</surname> <given-names>A</given-names></name>
<name><surname>Kumar</surname> <given-names>R</given-names></name>
<etal/>
</person-group>. 
<article-title><italic>Taenia solium</italic> cysticerci extracellular vesicles attenuate the AKT/mTORC1 pathway for alleviating DSS-induced colitis in a murine model</article-title>. <source>J Extracell Vesicles</source>. (<year>2024</year>) <volume>13</volume>:<fpage>e12448</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jev2.12448</pub-id>, PMID: <pub-id pub-id-type="pmid">38779712</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1401127">Yukifumi Nawa</ext-link>, Khon Kaen University, Thailand</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/482424">Nata&#x161;a Radulovi&#x107;</ext-link>, University of Belgrade, Serbia</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1402703">Yujian Wang</ext-link>, Huizhou University, China</p></fn>
</fn-group>
</back>
</article>